Infection control during gastrointestinal endoscopy

Canadian Journal of Gastroenterology

Volumn 21, Issue 1, 2007, Pages 13-15

  Nelson, Douglas B ^a   Adams, Paul C ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DISINFECTANT AGENT;

ANTIBIOTIC RESISTANCE; BACTERIUM CONTAMINATION; CLINICAL PROTOCOL; DISEASE COURSE; DISEASE TRANSMISSION; DISINFECTION; EDITORIAL; GASTROINTESTINAL ENDOSCOPY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 33847098247     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/169846     Document Type: Editorial

References (14)

1. American Society for Gastrointestinal Endoscopy. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Gastrointest Endosc 2003;58:1-8.
2. Nelson DB. Infectious disease complications of GI endoscopy: Part II, exogenous infections. Gastrointest Endosc 2003;57:695-711.
3. Ciancio A, Manzini P, Castagno F, et al. Digestive endoscopy is not a major risk factor for transmitting hepatitis C virus. Ann Intern Med 2005;142:903-9.
4. Anderson RL, Can JH, Bond WW, Favero MS. Susceptibility of vancomycin-resistant enterococci to environmental disinfectants. Infect Control Hosp Epidemiol 1997;18:195-9.
5. Rutala WA, Stiegel MM, Sarubbi FA, Weber DJ. Susceptibility of antibiotic-susceptible and antibiotic-resistant hospital bacteria to disinfectants. Infect Control Hosp Epidemiol 1997;18:417-21.
6. Rabenau HF, Kampf G, Cinatl J, Doerr HW. Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect 2005;61:107-11.
7. Dyas A, Das BC. The activity of glutaraldehyde against Clostridium difficile. J Hosp Infect 1985;6:41-5.
8. Hughes CE, Gebhard RL, Peterson LR, Gerding DN. Efficacy of routine fiberoptic endoscope cleaning and disinfection for killing Clostridium difficile. Gastrointest Endosc 1986;32:7-9.
9. Rutala WA, Gergen MF, Weber DJ. Inactivation of Clostridium difficile spores by disinfectants. Infect Control Hosp Epidemiol 1993;14:36-9.
10. Food and Drug Administration. Guidance for industry and FDA reviewers: Content and format of premarket notification [510(k)] submissions for liquid chemical sterilants/high level disinfectants. (Version current at November 27, 2006).
11. Nelson DB. Infectious disease complications of GI endoscopy: Part I, endogenous infections. Gastrointest Endosc 2003;57:546-56.
12. Chou R, Clark EC, Helfand M; US Preventive Services Task Force. Screening for hepatitis C virus infection: A review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2004;140:465-79.
13. Vavricka SR, Imhof A, Wildi S, et al. Air suctioning during colon biopsy acquisition reduces bacterial contamination. Gastrointest Endosc 2006;63:AB108.
14. Wildi SM, Imhof A, Vavricka SR, et al. Air contamination of procedure rooms in a gastroenterological unit with enteric bacteria. Gastrointest Endosc 2006;63:AB113.